These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12965224)
41. Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating hormone-induced cyclic adenosine 5'-monophosphate response element binding protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and increases CREB phosphorylation in corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Sarkar S; Lechan RM Endocrinology; 2003 Jan; 144(1):281-91. PubMed ID: 12488356 [TBL] [Abstract][Full Text] [Related]
42. Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats. Roseberry AG Psychopharmacology (Berl); 2013 Mar; 226(1):25-34. PubMed ID: 23010797 [TBL] [Abstract][Full Text] [Related]
43. Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis. Gavini CK; Jones WC; Novak CM J Physiol; 2016 Sep; 594(18):5285-301. PubMed ID: 27126579 [TBL] [Abstract][Full Text] [Related]
44. Alpha-melanocyte stimulating hormone and ghrelin: central interaction in feeding control. Olszewski PK; Bomberg EM; Grace MK; Levine AS Peptides; 2007 Oct; 28(10):2084-9. PubMed ID: 17719137 [TBL] [Abstract][Full Text] [Related]
45. Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Song CK; Vaughan CH; Keen-Rhinehart E; Harris RB; Richard D; Bartness TJ Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R417-28. PubMed ID: 18550869 [TBL] [Abstract][Full Text] [Related]
46. Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation. Patten CS; Daniels D; Suzuki A; Fluharty SJ; Yee DK Regul Pept; 2007 Aug; 142(3):111-22. PubMed ID: 17376547 [TBL] [Abstract][Full Text] [Related]
47. Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. Mounien L; Do Rego JC; Bizet P; Boutelet I; Gourcerol G; Fournier A; Brabet P; Costentin J; Vaudry H; Jégou S Neuropsychopharmacology; 2009 Jan; 34(2):424-35. PubMed ID: 18536705 [TBL] [Abstract][Full Text] [Related]
48. Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins. Skibicka KP; Grill HJ Endocrinology; 2009 Dec; 150(12):5351-61. PubMed ID: 19854868 [TBL] [Abstract][Full Text] [Related]
49. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Azzara AV; Sokolnicki JP; Schwartz GJ Physiol Behav; 2002 Nov; 77(2-3):411-6. PubMed ID: 12419417 [TBL] [Abstract][Full Text] [Related]
50. Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Hansen MJ; Schiöth HB; Morris MJ Brain Res; 2005 Mar; 1039(1-2):137-45. PubMed ID: 15781055 [TBL] [Abstract][Full Text] [Related]
51. Involvement of alpha-melanocyte stimulating hormone (alpha-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Kokare DM; Singru PS; Dandekar MP; Chopde CT; Subhedar NK Brain Res; 2008 Jun; 1216():53-67. PubMed ID: 18499089 [TBL] [Abstract][Full Text] [Related]
52. Effects of alpha-melanocyte-stimulating hormone on magnocellular oxytocin neurones and their activation at intromission in male rats. Caquineau C; Leng G; Guan XM; Jiang M; Van der Ploeg L; Douglas AJ J Neuroendocrinol; 2006 Sep; 18(9):685-91. PubMed ID: 16879167 [TBL] [Abstract][Full Text] [Related]
53. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. Glavas MM; Joachim SE; Draper SJ; Smith MS; Grove KL Endocrinology; 2007 Jul; 148(7):3279-87. PubMed ID: 17412803 [TBL] [Abstract][Full Text] [Related]
54. Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat. Williams DL; Grill HJ; Weiss SM; Baird JP; Kaplan JM Psychopharmacology (Berl); 2002 Apr; 161(1):47-53. PubMed ID: 11967630 [TBL] [Abstract][Full Text] [Related]
55. Blockade of melanocortin transmission inhibits cocaine reward. Hsu R; Taylor JR; Newton SS; Alvaro JD; Haile C; Han G; Hruby VJ; Nestler EJ; Duman RS Eur J Neurosci; 2005 Apr; 21(8):2233-42. PubMed ID: 15869520 [TBL] [Abstract][Full Text] [Related]
56. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists. Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335 [TBL] [Abstract][Full Text] [Related]
57. Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus. Gautron L; Cravo RM; Elmquist JK; Elias CF Neuroscience; 2013 Jun; 240():70-82. PubMed ID: 23485805 [TBL] [Abstract][Full Text] [Related]
58. Neuroanatomical evidence for a role of central melanocortin-4 receptors and oxytocin in the efferent control of the rodent clitoris and vagina. Gelez H; Poirier S; Facchinetti P; Allers KA; Wayman C; Alexandre L; Giuliano F J Sex Med; 2010 Jun; 7(6):2056-2067. PubMed ID: 20345736 [TBL] [Abstract][Full Text] [Related]